lactic acid has been researched along with Adenoma, Prostatic in 6 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess whether patients in acute urinary retention from benign prostatic enlargement can be treated with a combined therapy comprising finasteride and a bioabsorbable self-reinforced poly L-lactic acid (SR-PLLA) urethral stent." | 9.09 | A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a biodegradable self-reinforced poly L-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from ( Hellström, P; Isotalo, T; Perttilä, I; Talja, M; Tammela, TL; Törmälä, P; Välimaa, T, 2001) |
| "To evaluate, in a pilot study, the efficacy and safety of combining a braided poly(lactic-co-glycolic acid) (PLGA, a copolymer of l-lactide and glycolide) urethral stent and dutasteride in the treatment of acute urinary retention (AUR) due to benign prostatic enlargement (BPE)." | 7.75 | Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study. ( Hänninen, V; Isotalo, T; Juuti, H; Kellomäki, M; Kotsar, A; Leppiniemi, J; Mikkonen, J; Talja, M; Tammela, TL, 2009) |
| "To assess whether patients with acute urinary retention from benign prostatic enlargement can be treated with a combined therapy comprising a bioabsorbable self-reinforced poly L-lactic acid (SR-PLLA) urethral stent and finasteride." | 7.70 | A pilot study of a bioabsorbable self-reinforced poly L-lactic acid urethral stent combined with finasteride in the treatment of acute urinary retention from benign prostatic enlargement. ( Isotalo, T; Talja, M; Tammela, TL; Törmälä, P; Välimaa, T, 2000) |
| "To assess whether patients in acute urinary retention from benign prostatic enlargement can be treated with a combined therapy comprising finasteride and a bioabsorbable self-reinforced poly L-lactic acid (SR-PLLA) urethral stent." | 5.09 | A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a biodegradable self-reinforced poly L-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from ( Hellström, P; Isotalo, T; Perttilä, I; Talja, M; Tammela, TL; Törmälä, P; Välimaa, T, 2001) |
| "This study aimed to use the biocompatibility features of the biodegradable polymers to prepare depot injectable finasteride (FIN) microspheres for the treatment of benign prostatic hyperplasia." | 3.83 | Optimisation of microstructured biodegradable finasteride formulation for depot parenteral application. ( Ahmed, OA; Hussein, AK; Mady, FM, 2016) |
| "To evaluate, in a pilot study, the efficacy and safety of combining a braided poly(lactic-co-glycolic acid) (PLGA, a copolymer of l-lactide and glycolide) urethral stent and dutasteride in the treatment of acute urinary retention (AUR) due to benign prostatic enlargement (BPE)." | 3.75 | Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study. ( Hänninen, V; Isotalo, T; Juuti, H; Kellomäki, M; Kotsar, A; Leppiniemi, J; Mikkonen, J; Talja, M; Tammela, TL, 2009) |
| "To assess whether patients with acute urinary retention from benign prostatic enlargement can be treated with a combined therapy comprising a bioabsorbable self-reinforced poly L-lactic acid (SR-PLLA) urethral stent and finasteride." | 3.70 | A pilot study of a bioabsorbable self-reinforced poly L-lactic acid urethral stent combined with finasteride in the treatment of acute urinary retention from benign prostatic enlargement. ( Isotalo, T; Talja, M; Tammela, TL; Törmälä, P; Välimaa, T, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, SC | 1 |
| Zhao, H | 1 |
| Liu, R | 1 |
| Wang, BL | 1 |
| Liu, YQ | 1 |
| Zhao, Y | 1 |
| Shi, ZD | 1 |
| Ahmed, OA | 1 |
| Hussein, AK | 1 |
| Mady, FM | 1 |
| Kotsar, A | 1 |
| Isotalo, T | 3 |
| Juuti, H | 1 |
| Mikkonen, J | 1 |
| Leppiniemi, J | 1 |
| Hänninen, V | 1 |
| Kellomäki, M | 1 |
| Talja, M | 3 |
| Tammela, TL | 3 |
| Välimaa, T | 2 |
| Törmälä, P | 2 |
| Hellström, P | 1 |
| Perttilä, I | 1 |
| Dimberg, M | 1 |
| Allgén, LG | 1 |
| Norlén, H | 1 |
1 trial available for lactic acid and Adenoma, Prostatic
| Article | Year |
|---|---|
A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a biodegradable self-reinforced poly L-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from
Topics: Absorbable Implants; Aged; Aged, 80 and over; Combined Modality Therapy; Double-Blind Method; Enzyme | 2001 |
5 other studies available for lactic acid and Adenoma, Prostatic
| Article | Year |
|---|---|
[Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells].
Topics: Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glucose; Humans; Lacti | 2017 |
Optimisation of microstructured biodegradable finasteride formulation for depot parenteral application.
Topics: Animals; Biocompatible Materials; Caproates; Delayed-Action Preparations; Drug Compounding; Finaster | 2016 |
Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
Topics: Acute Disease; Aged; Aged, 80 and over; Azasteroids; Biocompatible Materials; Dutasteride; Enzyme In | 2009 |
A pilot study of a bioabsorbable self-reinforced poly L-lactic acid urethral stent combined with finasteride in the treatment of acute urinary retention from benign prostatic enlargement.
Topics: Acute Disease; Aged; Aged, 80 and over; Ambulatory Care; Combined Modality Therapy; Enzyme Inhibitor | 2000 |
Absence of lactate accumulation on transurethral resection of the prostate using 2.5% sorbitol solution as an irrigating fluid.
Topics: Blood Glucose; Fructose; Humans; Lactates; Lactic Acid; Male; Phosphates; Postoperative Complication | 1988 |